These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17870531)

  • 1. Synthesis of novel anilinoquinolines as c-fms inhibitors.
    Smalley TL; Chamberlain SD; Mills WY; Musso DL; Randhawa SA; Ray JA; Samano V; Frick L
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6257-60. PubMed ID: 17870531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor.
    Pawar VG; Sos ML; Rode HB; Rabiller M; Heynck S; van Otterlo WA; Thomas RK; Rauh D
    J Med Chem; 2010 Apr; 53(7):2892-901. PubMed ID: 20222733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based optimization of a potent class of arylamide FMS inhibitors.
    Meegalla SK; Wall MJ; Chen J; Wilson KJ; Ballentine SK; Desjarlais RL; Schubert C; Crysler CS; Chen Y; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Illig CR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3632-7. PubMed ID: 18495479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 3-amido-4-anilinoquinolines as potent and selective inhibitors of CSF-1R kinase.
    Scott DA; Balliet CL; Cook DJ; Davies AM; Gero TW; Omer CA; Poondru S; Theoclitou ME; Tyurin B; Zinda MJ
    Bioorg Med Chem Lett; 2009 Feb; 19(3):697-700. PubMed ID: 19112018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.
    Gong Y; Barbay JK; Buntinx M; Li J; Wauwe JV; Claes C; Lommen GV; Hornby PJ; He W
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3852-5. PubMed ID: 18595693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor.
    Scott DA; Dakin LA; Del Valle DJ; Diebold RB; Drew L; Gero TW; Ogoe CA; Omer CA; Repik G; Thakur K; Ye Q; Zheng X
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1382-4. PubMed ID: 21295474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMS.
    Burns CJ; Harte MF; Bu X; Fantino E; Giarrusso M; Joffe M; Kurek M; Legge FS; Razzino P; Su S; Treutlein H; Wan SS; Zeng J; Wilks AF
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1206-9. PubMed ID: 19128971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
    Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitors.
    Wall MJ; Chen J; Meegalla S; Ballentine SK; Wilson KJ; DesJarlais RL; Schubert C; Chaikin MA; Crysler C; Petrounia IP; Donatelli RR; Yurkow EJ; Boczon L; Mazzulla M; Player MR; Patch RJ; Manthey CL; Molloy C; Tomczuk B; Illig CR
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2097-102. PubMed ID: 18289848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel FMS kinase inhibitors as anti-inflammatory agents.
    Illig CR; Chen J; Wall MJ; Wilson KJ; Ballentine SK; Rudolph MJ; DesJarlais RL; Chen Y; Schubert C; Petrounia I; Crysler CS; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Meegalla SK
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1642-8. PubMed ID: 18242992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent 2'-aminoanilide inhibitors of cFMS as potential anti-inflammatory agents.
    Patch RJ; Brandt BM; Asgari D; Baindur N; Chadha NK; Georgiadis T; Cheung WS; Petrounia IP; Donatelli RR; Chaikin MA; Player MR
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6070-4. PubMed ID: 17904845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n=6, 7). Part 5.
    Chen YL; Lin HC; Yang CN; Lu PJ; Tzeng CC
    Chem Biodivers; 2008 Feb; 5(2):267-78. PubMed ID: 18293440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrido[2,3-d]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors.
    Huang H; Hutta DA; Rinker JM; Hu H; Parsons WH; Schubert C; DesJarlais RL; Crysler CS; Chaikin MA; Donatelli RR; Chen Y; Cheng D; Zhou Z; Yurkow E; Manthey CL; Player MR
    J Med Chem; 2009 Feb; 52(4):1081-99. PubMed ID: 19193011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.
    Swahn BM; Xue Y; Arzel E; Kallin E; Magnus A; Plobeck N; Viklund J
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1397-401. PubMed ID: 16337120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors.
    Wilson KJ; Illig CR; Chen J; Wall MJ; Ballentine SK; DesJarlais RL; Chen Y; Schubert C; Donatelli R; Petrounia I; Crysler CS; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Meegalla SK
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3925-9. PubMed ID: 20570147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
    Frotscher M; Ziegler E; Marchais-Oberwinkler S; Kruchten P; Neugebauer A; Fetzer L; Scherer C; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
    J Med Chem; 2008 Apr; 51(7):2158-69. PubMed ID: 18324762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
    Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors.
    Kravchenko DV; Kysil VV; Ilyn AP; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1841-5. PubMed ID: 15780618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives.
    Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A
    Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.